Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
Online Viagra, And This Time It's The Real Deal
(Wall Street Journal/Corporate Intelligence blog) May 6, 2013 - Drugmaker Pfizer is setting up an online ordering system for the erectile disfunction pill, in an effort to counter the widespread fraudulent sale of online counterfeits.
read article (paid subscription required) 
FDA Warns Pregnant Migraine Sufferers Against Anti-seizure Drugs
(Los Angeles Times) May 6, 2013 - The Food and Drug Administration is warning physicians that women who suffer migraine headaches and are pregnant or may become pregnant should not use the drugs valproate or valproic acid to prevent the severe headaches, in light of new evidence showing those taking the drugs during pregnancy have children with lower IQ scores than women who do not take them.
read article (free registration required)
Baxter Immunoglobulin Fails to Aid Alzheimer’s Patients
(Bloomberg) May 7, 2013 - Baxter International Inc.’s Gammagard failed to help patients with Alzheimer’s disease in a late-stage study, adding to a string of failures to develop a treatment for the most common form of dementia.
read article
Getting to the Right Relationship Between Doctors and Drug Companies
(The Atlantic) May 7, 2013 - We should strive to cultivate, not demonize, productive collaboration between physicians and pharma.
read article
Slowdown in Health Costs’ Rise May Last as Economy Revives
(New York Times) May 6, 2013 - One of the economic mysteries of the last few years has been the bigger-than-expected slowdown in health spending, a trend that promises to bolster wages and help close the wide federal deficit over the long term — but only if it persists.
read article
Conquer Cancer Foundation Recognizes Outstanding ASCO Annual Meeting Research; Announces Diversity in Oncology Awards
(Conquer Cancer Foundation) May 7, 2013 - The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) announces today the recipients of the 2013 Conquer Cancer Foundation of ASCO Merit Awards, Resident Travel Awards, Medical Student Rotation Awards and Oncology Travel Trainee Awards.
read press release
California: Court Upholds Ban on Marijuana Dispensaries
(New York Times) May 6, 2013 - The California Supreme Court on Monday upheld the right of local governments to ban medical marijuana dispensaries.
read article
Tennessee Oncology Chooses Navigating Cancer's Patient Engagement Portal
(Yahoo! Finance) May 7, 2013 - Navigating Cancer, the leading provider of oncology specific patient portals, announces that Tennessee Oncology has selected Navigating Cancer's Patient Engagement Portal for its practices and patients.
read article
Surveys Reveal Opportunity for Medical Community to Fully Embrace Biomarker Testing in Lung Cancer
(Reuters) May 7, 2013 - Boehringer Ingelheim Pharmaceuticals, Inc. today announced results of two surveys that explored how pulmonologists and pathologists are incorporating biomarker testing into the care of patients with lung cancer.
read article
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
(Sacramento Bee) May 6, 2013 - The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.
read article
EU Regulatory Authorities Grant Orphan Status to Eisai's Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
(Reuters) May 6, 2013 - Eisai Co Ltd announced that the investigational multi-tyrosine kinase inhibitor (TKI), lenvatinib (development code: E7080), has been granted orphan drug designation (ODD) for the treatment of follicular and papillary thyroid cancer by the European Commission.
read article
Eisai Files for Indication Expansion of Anticancer Agent Halaven® with European Medicines Agency
(Eisai) May 7, 2013 - Eisai Co., Ltd. announced today that its U.K. subsidiary, Eisai Europe Ltd., has filed an application with the European Medicines Agency (EMA) for anticancer agent Halaven® (eribulin mesylate, “eribulin”), requesting an indication expansion of eribulin to contribute to earlier-line treatment of patients with metastatic breast cancer.
read corporate press release
Concert Pharma To Get $300M+ Per Drug in Celgene Pact
(Xconomy Boston) May 6, 2013 - The past 15 months have turned into a partnership symphony for Concert Pharmaceuticals.
read article
Fire Aveo's CEO for Incompetence and Arrogance Rivaling ImClone's Sam Waksal
(TheStreet) May 6, 2013 - Heads need to roll at Aveo because of the FDA's thrashing of the company's kidney cancer drug.
read article
Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
(Denver Post) May 6, 2013 - Array BioPharma Inc. today announced that it will initiate a global Phase 3 clinical trial in patients with recurrent low-grade serous ovarian cancer (LGSOC) during the summer of 2013.
read article
Religious Support Tied to Intensive End-of-life Care
(Reuters Health) May 7, 2013 - People with advanced cancer tend to get more aggressive care at the end of life and spend more time in the intensive care unit if they receive spiritual support from their religious communities, according to a new study.
read article
Experimental Drug Beneficial in NIH Trial to Treat a Rare Sarcoma
(NCI) May 2, 2013 - Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib.
read press release
Exercise Could Reduce Bone Tumor Growth
(Cornell Chronicle) May 6, 2013 - Weight-bearing exercise, often prescribed to combat bone loss, might have anti-cancer effects. Cornell biomedical researchers report that mechanical stimulation of cancerous bone, in making bone stronger, seems to make tumors weaker.
read article
Exercise-related Changes in Estrogen Metabolism May Lower Breast Cancer Risk
(AACR) May 7, 2013 - Changes in estrogen breakdown, or metabolism, may be one of the mechanisms by which aerobic exercise lowers a woman’s breast cancer risk, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
read press release
Sleep Problems Linked to Increased Prostate Cancer Risk
(NBC News) May 7, 2013 - Men who have a hard time falling asleep and staying asleep may be at an increased risk of prostate cancer, according to a new study from Icelandic and American researchers.
read article
Study: Bladder Cancer Could Reoccur Despite Bladder Removal
(UT Southwestern) May 7, 2013 – Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests.
read press release
FDA Proposes New Tanning-Bed Warnings
(Time Healthland) May 6, 2013 - If the FDA gets its way, tanning beds may soon feature labels warning young people to steer clear of the machines and their jolts of UV radiation.
read article
Doctors to Older, Heavy Smokers: Get CT Screening for Lung Cancer
(Reuters) May 7, 2013 - Stepping into the debate over who should be screened for lung cancer, a leading medical specialty group issued new guidelines on Tuesday recommending that doctors offer annual low-dose CT (computed tomography) scanning to people whose age and smoking history puts them at significant risk of lung cancer.
read article
Unmeltable, Uncrushable: The Holy Grail in Painkillers
(Wall Street Journal) May 5, 2013 - The arms race to build a safer painkiller is under way. In the wake of a key decision by the Food and Drug Administration, more than a dozen pharmaceutical companies—from startups to Pfizer Inc. are vying to create painkilling drugs that are difficult to abuse.
read article (paid subscription required)
AbbVie's Investigational Hepatitis C Virus Regimen Gets Breakthrough-Therapy Designation
(Morningstar/Dow Jones Newswires) May 6, 2013 - AbbVie Inc. said its investigational regimen for the hepatitis C virus obtained a breakthrough-therapy designation from the U.S. Food and Drug Administration.
read article
.jpg)